Now, orthopedic startups have a new go-to website to guide them. OrthoWorx, based in Warsaw, Indiana, has announced the launch of the website for AcceLINX, its initiative to advance business in the musculoskeletal space.
OrthoWorx’s AcceLINX Launches Website
1 min read Premium comments
Secondary
“We’re delighted to launch this visible symbol of AcceLINX progress and to begin to more formally engage with innovative entrepreneurs in musculoskeletal health,” said Sheryl Conley, president and CEO of OrthoWorx and board member of AcceLINX, in the March 8, 2017 news release. “One sign of great interest in the AcceLINX model is that we’ve already had preliminary conversations with more than 20 start-ups and entrepreneurs who are interested in engaging with AcceLINX, either as a funded, supported portfolio company or as a fee-for-service client.”
“We are currently working with a dedicated team of successful musculoskeletal health industry executives and investment professionals to provide qualified start-ups with access to needed capital to fund growth,” Conley added.
Sheryl Conley told OTW, “In meeting with more than 20 start-ups, we’ve found that they are interested in the attributes that we can uniquely provide—people with vast industry experience to advise and support them; a network with proven providers in services, distribution, commercial operations and clinical experience; and a connection to the capital that they need to grow. They’ve told us they would value a relationship with AcceLINX because of our very specific concentration in musculoskeletal health.”
“Our recent announcement regarding the AcceLINX website signifies that we are ready to formally engage and support potential start-up partners via fee-for-service consulting arrangements. Unlike other accelerators that take more of a ‘boot camp’ or co-working approach, we will be directly engaging with start-ups and will be intimately involved as they progress. We do plan to launch a webcast speaker series in the next couple of months in an effort to provide some education to a broader audience on highly relevant topics.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.